Vivian Smith's Walk to End Alzheimer's Page

Share My Page

Join My Team Donate

I am committed to raising awareness and funds for Alzheimer's research, care and support. I will continue to do so for the rest of my life or until there is a cure.

So please join me and the Residences at Vantage Point (formerly known as Vantage House) in this monumental cause as we walk together in support of our loved ones; our residents that we serve; our friends; our family; and our future.

The end of Alzheimer's disease starts here.

Will you join us?

Join My Team Donate Now

My Walk

My Team

RESIDENCES AT VANTAGE POINT (Vantage House)

Join My Team

My Walk
2021 Walk to End Alzheimer's - Ellicott City, MD (Howard County)
Saturday, September 25, 2021

My Team

My Team

View: RESIDENCES AT VANTAGE POINT (Vantage House)

Join My Team

Top Donors

Fundraising Honor Roll

Columbia Vantage House Corp.

$434

Stephanie Lyon

$400

Paula J Rasera

$365

Patricia Wilson

$250

Joanne LaPorte

$150

Vedron Bordeaux

$120

James Bell

$100

Leon A Rosenberg Jeffrey R Rosenberg

$100

Stephen Sternheimer

$100

Susan Stollman

$50

Lori Kbssoh

$50

Vivian O Smith

$50

Barbara Kaplan & David Zeitzer

$50

Susan Buswell

$50

Joanne LaPorte

$50

Kimberly Williams

$50

Lynn Perlin

$50

Diane Caplan

$50

Neal Myers

$50

John Lyons

$50

Stephen Sternheimer

$50

Columbia Vantage House Corp. - Vivian Smith

$36

Oakley Branch

$35

David Bixler

$30

William and Mary Ruth Alter

$30

Michale Glasgow

$30

Patricia Latteri

$25

Penelope Zervos Revoc Liv Trt Penelope Zervos Ttee

$25

James and Emilie Sanborn

$25

Bert Smith

$25

Joyce Thompson

$25

Gail Broida

$25

John & Carol Roberts

$20

Mark Goins

$20

Richard Bush

$20

Barry Blyveis

$20

Joel Morris

$20

Carolyn Ehrlich

$20

Ann Wing

$16

Bobbi Fagan

$15

Stephen Sternheimer

$10

Jim Gutman

$10

Suzanna Merritt

$10

Mike Premeph

Francine Sheppard

Donate

Use of Funds

The mission of the Alzheimer's Association is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Learn More.